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Abstract
Objectives: We aimed to show an area-level association bet-
ween the frequency of intestinal metaplasia (IM) in Helicobacter
pylori-infected patients and tobacco consumption.
Methods: We systematically reviewed the literature to retrieve
data on the prevalence of IM in different countries and per-
formed an ecological analysis to quantify the association bet-
ween the prevalence of IM among infected subjects and smo-
king, using data on national tobacco availability. Articles
evaluating IM in the general population or in dyspeptic patients
were identified by a MEDLINE search. We selected one study
per country, giving preference to those for which the study de-
sign/populations evaluated provided the highest external va-
lidity and inter-study comparability of methodology.
Results: This systematic review of published data retrieved
information for 29 countries from 5 continents depicting a wide
variation in the prevalence of IM among H. pylori-infected sub-
jects in different regions, ranging from 3% in Argentina to 55%
in New Zealand. In countries exhibiting a simultaneously high
prevalence of infection and low incidence of gastric cancer,
IM was also relatively infrequent (Thailand, 6%; India, 8.2%;
Nigeria, 11.1%; Gambia, 11.8%; Saudi Arabia, 15.5%; Iran,
15.6%; Egypt, 24.4%). A significant correlation was observed
between IM prevalence in infected subjects and tobacco avai-
lability (r = 0.45; p = 0.02).
Conclusions: Our results show that the concept of the Afri-
can and Asian «enigmas» may be extended to precancerous
lesions. Tobacco availability was positively associated with the
prevalence of IM among H. pylori-infected subjects at an area
level.
Key words: Intestinal metaplasia. Smoking. Helicobacter py-
lori. Systematic review. Ecological study.
Resumen
Objetivos: Evaluar la asociación entre la frecuencia de me-
taplasia intestinal (MI) en los sujetos infectados por Helico-
bacter pylori y el consumo de tabaco.
Métodos: Revisión sistemática de la literatura médica para
obtener datos de la prevalencia de MI en diferentes países y
análisis ecológico para cuantificar la asociación entre preva-
lencia de MI en los infectados y la disponibilidad de tabaco
en cada país. En una búsqueda a través de MEDLINE se iden-
tificaron artículos en los que se evalúan casos de MI en la
población general o en pacientes dispépticos. Para seleccio-
nar un artículo por cada país, se han elegido aquellos en que
el estudio del diseño/población evaluado proporcionaba una
mayor validez externa y comparabilidad.
Resultados: Se han seleccionado 22 artículos que contenían
datos para 29 países de los 5 continentes, describiendo la gran
variabilidad de la prevalencia de MI en los sujetos infectados
en los diferentes países, desde el 3% en Argentina hasta el
55% en Nueva Zelanda. En los países que presentaban si-
multáneamente una prevalencia de infección alta y una inci-
dencia de cáncer gástrico baja, la MI era también relativamente
infrecuente (Tailandia, 6%; India, 8,2%; Nigeria, 11,1%;
Gambia, 11,8%; Arabia Saudí, 15,5%; Irán, 15,6%; Egipto,
24,4%). Se observó una correlación significativa entre la pre-
valencia de MI en los infectados y la disponibilidad de taba-
co (r = 0,45; p = 0,02).
Conclusiones: Nuestros resultados muestran que el concepto
de «enigmas» africano y asiático se puede extender a las le-
siones precancerosas. Desde la perspectiva de un estudio eco-
lógico, la disponibilidad de tabaco se asocia con la prevalen-
cia de MI en los sujetos infectados por H. pylori.
Palabras clave: Metaplasia intestinal. Tabaco. Helicobacter
pylori. Revisión sistemática. Estudio ecológico.
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Introduction
S
tomach cancer is one of the most frequent can-
cers, both in developed and developing countries,
with a wide variation in incidence and mortality rates
across geographical areas1. «Intestinal» gastric car-
cinomas, which are the most frequent variety and to which
regional differences in the incidence of gastric cancer are
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attributed2, are preceded by atrophic gastritis, intestinal
metaplasia (IM), and dysplasia. They follow a set of se-
quential steps3 which is amenable to modulation by en-
vironmental and individual susceptibility factors.
Helicobacter pylori is the most important4 risk fac-
tor for gastric cancer5,6 and its precursor lesions7,8.
Among other environmental exposures, low fruit and ve-
getable consumption9 and smoking10,11 are established
risk factors for gastric cancer. Several studies have also
addressed the association between different lifestyles
and the occurrence of precancerous gastric lesions, es-
pecially IM. Smoking is the most extensively studied of
these lifestyle exposures and the one that most strongly
increases the risk of IM and IM progression12-18. With
respect to host genetic background, polymorphisms in
genes coding for pro-inflammatory cytokines (interleu-
kin-1B and its receptor antagonist) are responsible for 
increased susceptibility to the development of cancer19-21
and precancerous lesions22-24.
Regional differences in the virulence of H. pylori
strains25,26, host genetic profile27,28 and response to in-
fection29,30, and exposure to environmental hazards and
certain lifestyles31-33 have all been proposed as expla-
nations for the low incidence of gastric cancer in many
countries with a high-prevalence of infection: the so-ca-
lled African34 and Asian35 «enigmas».
Ecological32 and individual level36,37 evidence supports
the hypothesis of a synergistic effect between H. pylo-
ri and smoking, which suggests that the low cigarette
consumption found in most African and South-Eastern
Asian countries contributes to the low frequency of gas-
tric cancer in these regions, despite the high prevalen-
ce of infection. If an area-level association between the
prevalence of IM amongst the infected and smoking could
also be demonstrated, this would provide further sup-
port for the hypothesis that geographical variations in
the consumption of tobacco could help to explain these
«enigmas».
We thereby systematically reviewed the literature to
retrieve data on the prevalence of IM in different coun-
tries and performed an ecological analysis aimed at
quantifying the association between the prevalence of
IM in H. pylori-infected subjects and tobacco availabi-
lity in each country.
Methods
Data on the prevalence of IM were obtained through
a MEDLINE search using the following expression: me-
taplasia AND (stomach OR gastric) AND (prevalence
OR incidence OR epidemiology OR epidemio* OR prev*
OR incid*) NOT (case reports [ptyp])) AND (English[lang]
OR French[lang] OR Italian[lang] OR Spanish[lang] OR
Portuguese[lang]) AND (adult[MeSH]) AND (Hu-
mans[Mesh]) AND («1996/01/01»[EDat]:«2006/06/01»
[EDat]) in Pubmed (http://www.ncbi.nlm. nih.gov/en-
trez/query.fcgi?DB=pubmed). Four hundred and se-
venteen articles written in English, French, Italian, Spa-
nish or Portuguese and published between January 1st,
1996 and June 1st, 2006 were retrieved.
One reviewer (BP) screened all the references and,
after reviewing the titles and abstracts and/or the full ar-
ticles, excluded those that were clearly unrelated to the
study subject (e.g. laboratory research, family studies)
or that had an aim or sampling strategy that resulted in
the oversampling of subjects presenting atrophic gas-
tritis, IM, dysplasia, adenocarcinoma, esophageal, duo-
denal (e.g. trials performed on subjects with gastric pre-
cancerous lesions, studies in which the sampling
strategy did not include a random or consecutive sam-
ple of subjects undergoing upper digestive endoscopy)
or other non-gastric conditions (e.g. cohorts or case-
series of patients with other diseases). When more than
one figure was available for a given country, preferen-
ce was given to studies that analyzed more than one
country (to ensure greater comparability of the methods
used to assess IM), had national coverage, evaluated
random samples of the general population or had the
largest sample size. The previous criteria were consi-
dered in the above-mentioned order in order to select
one report per country. A flow-chart of the review is pre-
sented in figure 1.
Results from 29 countries, obtained from 22 articles,
were included in the systematic review12,38-58. For each
study, we extracted information on the country, year of
publication (the dates when the studies where perfor-
med were only available for 5 studies), characteristics
of the subjects evaluated, sample size, gender and age
of the participants, biopsy sites, and IM prevalence in
H. pylori-infected individuals, in non-infected subjects
and in the sample as a whole. A summary of the cha-
racteristics of the studies included in the systematic re-
view is presented in table 1 and data about IM preva-
lence is in table 2.
Estimates of tobacco availability in each country (ap-
parent adult tobacco consumption expressed as ciga-
rettes per adult per day) were obtained for 1990-1992
from the Tobacco and Health Report59, or for the nea-
rest available year from the National Tobacco Informa-
tion Online System (NATIONS) database60 when no data
were presented in the previous source (table 3).
For the ecological analysis, we considered the pre-
valence of IM in antrum biopsies of H. pylori-infected
subjects. When the site of the biopsy sampling was not
specified, we considered prevalence figures, regardless
of the location of the lesions. When data on IM preva-
lence were not presented separately for infected and
non-infected individuals38,44,46,51, we assumed that all the
cases of IM occurred within the group of infected sub-
jects. When H. pylori status was not analysed in the
study, we considered the overall prevalence, regardless
of infection status43,47,58. One country had no available
data on the consumption of cigarettes in the databases
searched and was therefore excluded from the ecolo-
gical analysis57.
Pearson’s correlation coefficients were computed to
quantify the association between IM prevalence among
the infected and tobacco availability (table 4). Data analy-
sis was performed using STATA», version 9.2.
Results
Data on IM prevalence were obtained for 29 countries:
3 African (one from Northern and two from Western Afri-
ca), 6 American (one from North, one from Central and
four from South American countries), 9 Asian (three from
Eastern, 3 from Western and 3 from Southern Asia), 9
European (4 from Northern, 2 from Southern, 2 from Wes-
tern, and one from Central/Eastern Europe), and 2 from
Oceania (Australia and New Zealand) (table 1).
The median number of subjects evaluated in each
study was 250, with sample sizes ranging from 45 to
2199. All reports included both males and females, but
the number of subjects evaluated according to gender
was only available for 18 countries. Among the latter,
the median male/female ratio was 1.1, ranging from 0.6
to 3.2. Most studies evaluated samples with a wide age-
range (from young adulthood to over 65), but 8 inclu-
ded participants aged below 18 (as specified by the aut-
hors or estimated assuming the minimum age as the
mean minus 2 standard deviations) and 3 only enrolled
participants who were over 40 years old. Twenty-five stu-
dies were carried out in a hospital setting, evaluating
dyspeptic patients (table 1).
The median number of biopsy specimens colleted
was 4, ranging from 2 to 13. The data from 17 studies
were based on the Sydney system, while one followed
the Whitehead classification, and 11 reports did not spe-
cify the criteria used for histological assessment (table
1). Seventeen studies provided information on antrum
IM prevalence, while the other only presented data for
the frequency of IM, without specifying the location of
the lesions found. Seven reports did not present data
for IM prevalence by H. pylori infection status (table 2).
The median prevalence of IM among H. pylori-in-
fected individuals was 23.6%, ranging from 3% in Ar-
gentina to 55% in New Zealand. In countries presen-
ting a simultaneously high prevalence of infection and
low gastric cancer incidence32, IM was also infrequent
(Thailand, 6%; India, 8.2%; Nigeria, 11.1%; Gambia,
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Figure 1. Flow-chart followed when performing the systematic review
< 17 articles
263 articles were excluded based on the abstract because they were clearly unrelated to our
study or performed an oversampling presenting atrophic gastritis, intestinal metaplasia,
dysplasia, adenocarcinoma, oesophageal, duodenal or other non-gastric conditions
154 articles were retrieved for further analysis
20 articles were excluded based on the full text because they performed an oversampling of
subjects presenting atrophic gastritis, intestinal metaplasia, dysplasia, adenocarcinoma,
oesophageal, duodenal or other non-gastric conditions
125 articles
103 articles (presenting data for countries) were excluded because when more than one figure
was available for the same country we opted for studies that analyzed more than one country
or with a national coverage, using random samples of the general population, with the largest
sample size
22 articles were selected presenting data for 29 countries
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Table 1. Characteristics of the studies included in the systematic review
Characteristics Sample size Age Biopsy sites  Criteria for 
Country, reference of the subjects evaluated (M/F) (years)a (number ofspecimens) histological evaluation
Africa
Egypt43 Patients with dyspepsia 92 (69/23) 25-68 Antrum (2) Whitehead classification
Gambia44 Adults with dyspepsia 45 18-70 Body (1) Modified Sydney system
Antrum (2)
Incisura (1)
Nigeria51 Review of endoscopic gastric biopsies with 85 Not stated Not specified Not specified
a histological diagnosis of chronic gastritis
America
Argentina38 Symptomatic individuals who underwent upper 114 (80/34) 15-76 Antrum (1) Sydney system
gastrointestinal endoscopy as a control group for Body (1)
celiac disease cases
Colombia41 Patients with nonulcer dyspepsia as a control group 67 (39/28) 19-76 Antrum (5) Updated Sydney system
for gastric cancer cases Corpus (6)
Cardia (1)
Mexico49 Asymptomatic volunteers recruited through radio 368 > 40c Antrum (3) Updated Sydney system
announcements for gastric cancer screening Incisura (1)
Corpus (3)
Peru52 H. pylori-infected participants from 2 different 78 (29/49) 18-65 Antrum (6) Not specified
gastric cancer prevention programs, in which Body (4)
symptomatic patients were included Cardia (3)
United States of America53 H. pylori-infected individuals who underwent 147 (71/76) 57.4 ± 17.9b Antrum (not specified) Updated Sydney system
gastroscopic examination for mild epigastric Body (not specified)
symptoms or routine screening
Venezuela12 Gastric cancer screening program 2,199 (1041/1158)35-69 Antrum (4) Not specified
Corpus (1)
Asia
China40 Helicobacter pylori-infected subjects attending 598 18-75 Antrum (2) Updated Sydney system
gastroenterological clinics Corpus (2)
India45 Symptomatic patients 355 (263/92) 13-85 Not specified Sydney system
Iran46 General population, 2 districts 1,011 (494/517) 40-92 Incisura (1) Not specified
Antrum (2)
Cardia (2)
All visible lesions (variable)
Japan40 H. pylori-infected subjects attending 227 51.8 ± 12b Antrum (2) Updated Sydney system
gastroenterological clinics Corpus (2)
Republic of Korea53 H. pylori-infected individuals who underwent 181 (122/59) 50.9 ± 14.9b Antrum (not specified) Updated Sydney system
gastroscopic examination for mild epigastric Body (not specified)
symptoms or routine screening
Saudi Arabia54 Patients being investigated for chronic dyspepsia 778 (415/363) 10-100 Antrum (2) Not specified
Thailand40 H. pylori-infected subjects attending 243 48.3 ± 14b Antrum (1) Updated Sydney system
gastroenterological clinics Corpus (1)
Turkey56 Patients admitted to the endoscopic unit 210 (120/90) 20-80 Lesion (3) Not specified
Antrum (1)
United Arab Emirates57 Patients with upper abdominal symptoms that had 602 (458/144) 5-70 Not specified Not specified
failed to respond to H2 receptor antagonists 
or antiacids
Europe
Czech Republic42 Patients with dyspepsia and H. pylori infection 251 (110/141) 15-91 Antrum (2) Sydney system
Corpus (2)
Cardia (2)
Finland40 H. pylori-infected subjects attending 104 53.5 ± 10b Antrum (2)
gastroenterological clinics Corpus (2) Updated Sydney system
Germany40 H. pylori-infected subjects attending 250 54.1 ± 17b Antrum (2)
gastroenterological clinics Corpus (2) Updated Sydney system
(Continues)
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Table 1. Continued
Characteristics Sample size Age Biopsy sites  Criteria for 
Country, reference of the subjects evaluated (M/F) (years)a (number of specimens) histological evaluation
Ireland47 Patients presenting upper gastrointestinal 324 (168/156) 59 ± 14b Corpus (not specified) Not specified
symptoms Antrum (not specified)
Italy48 Non-ulcerous and untreated patients 267 (115/152) 14-84 Antrum (2) Not specified
Oxyntic mucosa (2)
Netherlands40 H. pylori-infected subjects attending 263 49.9 ± 13 b Antrum (2) Updated Sydney system
gastroenterological clinics
Portugal40 H. pylori-infected subjects attending 221 48.8 ± 16b Antrum (2) Updated Sydney system
gastroenterological clinics Corpus (2)
Sweden55 Random sample of participants that had been 1,000 (490/510) 20-80 Cardia (2) Updated Sydney system
surveyed using a gastrointestinal symptom Antrum (2)
questionnaire Corpus (2)
United Kingdom58 Patients presenting any degree of dyspepsia 1,753 > 40 c Not specified Not specified
and follow-up of those with lesions
Oceania
Australia39 Patients with dyspepsia or reflux symptoms 268 (130/138) 17-85 Antrum (3) Updated Sydney system
Body (2)
Fundus (2)
Incisura (1)
New Zealand50 Patients attending for endoscopy for dyspepsia 158 (92/66) 25-80 Juxtapylorus (2) Not specified
Antrum (2)
Body (2)
aMinimum-maximum, except when otherwise specified; bmean ± SD; clower limit of the age range not specified.
M: males; F: females. 
Table 2. Prevalence of intestinal metaplasia according to Helicobacter pylori infection status in 29 countries from 5 continents
Country, reference IM prevalence in H. pylori-infected subjects (%) IM prevalence in H. pylori-uninfected subjects (%) Overall IM prevalence (%)
Africa
Egypt43 Not provided Not provided Antrum – 24.4
Gambia44 Not provided Not provided 8.9
Nigeria51 Not provided Not provided 9.4
America
Argentina38 Not provided Not provided 1.8
Colombia41 40.7 30.8 38.8
Mexico49 Antrum – 21.5
Corpus – 9.8 – –
Peru52 Antrum – 29.5
Body – 10.2
Cardia – 0 – –
United States Antrum – 15
of America53 Body – 8.3 – –
Venezuela12 25.2 22.2 25
Asia
China40 Antrum – 33
Corpus – not specified – –
India45 8.2 2.9 6.5
Iran46 Not provided Not provided 13
Japan40 Antrum – 44
Corpus – not provided – –
Republic of Korea53 Antrum – 35.1
Body – 10.3 – –
Saudi Arabia54 Antrum – 15.5 Antrum – 14.1 Antrum – 15.2
(Continue)
11.8%; Saudi Arabia, 15.5%; Iran, 15.6%; Egypt,
24.4%) (table 3).
A moderately significant correlation was observed
between IM prevalence in infected subjects and tobacco
availability (r = 0.45; p = 0.02) (fig. 2). When conduc-
ting a sensitivity analysis taking different inclusion cri-
teria into account (table 4), the correlation coefficient
point estimates were similar to those observed in the
main analysis for most of the subgroups analyzed, with
values ranging between 0.42 and 0.55. The only ex-
ceptions were in studies providing IM prevalence in the
antrum (r = 0.33), studies providing IM prevalence in H.
pylori-infected subjects (r = 0.36) and studies involving
only asymptomatic subjects (r = 0.83).
Discussion
This systematic review of published data retrieved
information for 29 countries from the 5 continents sho-
wing a wide variation in the prevalence of IM among H.
pylori-infected subjects. We observed a moderate co-
rrelation between IM prevalence among H. pylori-infected
subjects and tobacco availability.
The search strategy adopted for the systematic re-
view included only articles published since 1996. These
studies were more likely to have followed a standardi-
zed approach to the interpretation of gastric biopsies
based on the updated Sydney System61. The criteria
used to select one study per country were also defined
with the aim of selecting the most reliable estimates, with
the highest levels of external validity and inter-study com-
parability of methodologies. Preference was given to ar-
ticles in which the evaluation of biopsies from patients
from different countries was performed by the same aut-
hors, which helped to guarantee more homogeneous
criteria in the biopsy sampling and interpretation. Stu-
dies covering asymptomatic populations within the
same country tend to better reflect the prevalence of IM
in the region in question and estimates obtained from
larger samples are more precise.
The broad inclusion criteria (the oversampling of sub-
jects with conditions known to increase the risk of IM
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Table 2. Continued
Country, reference IM prevalence in H. pylori-infected subjects (%) IM prevalence in H. pylori-uninfected subjects (%) Overall IM prevalence (%)
Thailand40 Antrum – 6
Corpus – not provided – –
Turkey56 44.9 57.4 48.1
United Arab Emirates57 34.5 14 28.9
Europe
Czech Republic42 Antrum – 54.6
Corpus – 13.9
Cardia – 44.2 – –
Finland40 Antrum – 33
Corpus – not provided – –
Germany40 Antrum – 22
Corpus – not provided – –
Ireland47 Not provided Not provided 24.1
Italy48 Antrum – 20.2
Oxyntic mucosa – 6.7 Antrum – 3.8
Oxyntic mucosa – 1.9 Antrum – 13.8
Oxyntic mucosa – 4.9
Netherlands40 Antrum – 26 – –
Portugal40 Antrum – 34.0
Corpus – not provided – –
Sweden55 Antrum – 23.6 Antrum – 1.9 Antrum – 11.3
Corpus – 13.9 Corpus – 1.9 Corpus – 7.1
United Kingdom58 Not provided Not provided 10.5
Oceania
Australia39 Antrum – 19.5 Antrum – 7.7 Antrum – 12.7
Body – 4.4 Body – 1.9 Body – 3
Fundus – 1.8 Fundus – 0.6 Fundus – 1.1
Incisura – 13.3 Incisura – 4.5 Incisura – 8.2
New Zealand50 55 26 47
IM: intestinal metaplasia.
was the main exclusion criterion) allowed an evaluation
of studies based on different methodological approaches.
Most of them involved dyspeptic and H. pylori-infected
patients, which naturally do not reflect the prevalence
of IM in the general population. Details of the latter could
be obtained by evaluating samples that are not pre-se-
lected according to gastrointestinal symptoms, but
such information is only available for a small number
of countries. However, our review provides important in-
formation on the frequency of IM among H. pylori-in-
fected subjects, which is not expected to differ subs-
tantially between dyspeptic and non-dyspeptic subjects,
between males and females, or over time.
Even if the evaluated populations are homogeneous,
the number and location of biopsy sites may contribu-
te to variability in the prevalence of IM62-64. The studies
included in this review showed substantial variation with
respect to biopsy sites, or in their description, impairing
full comparability between different countries. Here, ho-
wever, we present data for each specific stomach lo-
cation and most of the studies cited are based on the
results of antrum biopsies. The majority of papers con-
sulted presented information for IM at the antrum, with
the greatest prevalence being observed at this location,
which facilitated comparison.
Differences in the characteristics of the populations
studied with regard to age could compromise compa-
risons between different countries. Only 3 studies12,40,54
provided the information needed to obtain age-stan-
dardized IM prevalence estimates, but most of them in-
cluded subjects from a wide age-range. All of the stu-
dies evaluated both males and females, but the samples
do not necessarily reflect the sex ratio within the H. py-
lori-infected population.
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Table 3. Data used in the ecological study (prevalence 
of intestinal metaplasia (IM) in Helicobacter pylori-infected
subjects and tobacco availability)
IM prevalence in H. pylori- Tobacco availabilitya
Country, reference infected subjects (%) (cigarettes/day/adult)
Africa
Egypt43 24.4b 3.32
Gambia44 11.8c 1.11d
Nigeria51 11.1c 1.01
America
Argentina38 3.0c 4.41
Colombia41 40.7 4.79
Mexico49 21.5 2.66
Peru52 29.5 0.96
United States of America53 15.0 7.32
Venezuela12 25.2 5.26
Asia
China40 33.0 5.20
India45 8.2 3.75
Iran46 15.6c 2.55
Japan40 44.0 8.88
Republic of Korea53 35.1 8.25
Saudi Arabia54 15.5 5.84
Thailand40 6.0 2.88
Turkey56 44.9 5.75
Europe
Czech Republic42 54.6 6.84
Finland40 33.0 4.77
Germany40 22.0 6.46
Ireland47 24.1b 6.63
Italy48 20.2 5.26
Netherlands40 26.0 7.73
Portugal40 34.0 5.51
Sweden55 23.6 4.25
United Kingdom58 10.5b 6.05
Oceania
Australia39 19.5 7.42
New Zealand50 55.0 6.88
aData for the years 1990-1992 from the Tobacco and Health report of the World 
Health Organization (WHO)59, except when otherwise specified.
bNo information was available regarding the H. pylori infection status and the ove-
rall prevalence of IM was used.
cEstimated assuming that all the cases of IM occurred within the group of infected
subjects.
dInformation collected from the National Tobacco Information Online System (NA-
TIONS) database60 (1990-1992).
IM: intestinal metaplasia.
Table 4. Association between tobacco availability 
and prevalence of intestinal metaplasia in Helicobacter 
pylori-infected individuals according to different inclusion
criteria (sensitivity analysis)
Pearson’s 
correlation 
Inclusion criteria n coefficient p
All studies 28 0.45 0.02
Studies evaluating participants from 
more than one country 9 0.53 0.14
Studies with a sample size of more 
than 200 participants 18 0.52 0.03
Studies providing IM prevalence 
in the antrum 17 0.33 0.19
Studies providing IM prevalence 
in H. pylori-infected subjects 21 0.36 0.11
Studies specifying the use of the updated 
Sydney system for histological evaluation 14 0.49 0.07
Studies collecting 4 or more biopsy 
samples 17 0.55 0.02
Studies involving only asymptomatic 
subjects 4 0.83 0.17
Studies enrolling only individuals 
aged above 17 20 0.43 0.06
Studies not enrolling only individuals 
aged above 40 24 0.42 0.04
Studies with a male:female ratio > 1 9 0.51 0.16
Studies published after the year 2000 19 0.52 0.02
IM: intestinal metaplasia.
In addition to providing descriptive information on IM
prevalence for different countries, the systematic review
was also designed to provide data for an ecological analy-
sis, and this was reflected in the characteristics of the
search strategy. A more comprehensive search would pro-
bably provide information for a few more countries, but
we do not believe that the conclusions of our study would
be changed since we were able to include a large num-
ber of countries from five continents in our analysis.
The advantages and limitations of the ecological de-
sign are well-known65 and certain considerations must
be made with reference to the data sources and options
for analysis.
The information on the frequency of IM had the pre-
viously mentioned limitations and some assumptions had
to be made in order to include all of the countries in the
analysis, since not all the reports presented data in the
same format. Seven studies38,43,44,46,47,51,58 did not pro-
vide information on the frequency of IM in H. pylori-in-
fected subjects. They were therefore included in the eco-
logical analysis with the assumption either that the overall
prevalence of IM was the same as that among the in-
fected (Egypt, Ireland and United Kingdom), or that all
IM cases had occurred within the group of infected sub-
jects (Gambia, Nigeria, Argentina and Iran). This see-
med a reasonable and conservative option, since pre-
valence was underestimated in the former group (which
includes 2 countries with high cigarette availability and
a low or moderate IM prevalence) and overestimated
in the latter (which includes three countries with a low
IM prevalence and low cigarette availability). If the true
figures had been used, the correlation would probably
have been stronger. Furthermore, 5 of these studies were
conducted in countries with a predictably high preva-
lence of infection, so the error in our procedure was pro-
bably low. In sensitivity analysis, the exclusion of these
7 studies reduced the variability in exposure to tobac-
co and also the frequency of the outcome, compromi-
sing the yield of the ecological study and resulting in a
correlation coefficient of 0.36 (23% lower than that ob-
served in the main analysis). However, we computed
correlation coefficients for 11 subgroups of studies with
methodological characteristics that would favour the va-
lidity of our study and obtained similar results for most
of the different inclusion criteria considered. The sen-
sitivity analysis supported the robustness of our results,
when considering a small number of countries providing
prevalence estimates for IM.
The availability of cigarettes derived from production,
importation and exportation was used in this study to
estimate tobacco use, reflecting both the prevalence and
intensity of consumption. We assumed that the pro-
portion of available cigarettes consumed, the underre-
porting of availability, and the use of other forms of to-
bacco were similar for all countries.
The tobacco estimates used related to the period
1990-1992 and assumed a lag between exposure and
the onset of IM ranging from 5 to 15 years. We have,
however, also included in the analysis studies publis-
hed between 1996 and 2006, which probably refer to
surveys performed a few years earlier. The lag time con-
sidered in our study is probably of 5 to 10 years on ave-
rage. Our decision to opt for a time lag as short as 5
years, less than would normally be considered if the out-
come was cancer66, was based on the fact that our study
estimates the association between smoking and a pre-
cancerous lesion, which would be expected to appear
several years before the development of gastric cancer3.
The prevalence of IM and cigarette consumption is
strongly dependent on age and gender. An age- and
sex- standardization of the prevalence of IM and ciga-
rette consumption would have improved our analysis,
but unfortunately this was not possible with the data avai-
lable. It should, however, be acknowledged that we eva-
luated the frequency of IM among the H. pylori-infec-
ted population. This is less likely to be influenced by age
than the prevalence of IM in the general population. The
effect of the age and gender distributions within the sam-
ples evaluated in each study was considered in the sen-
sitivity analysis, showing no major differences in asso-
ciation between IM and smoking when different inclusion
criteria were considered relating to the age and gen-
der of the participants in each survey, except in studies
that evaluated more women than men.
The United Arab Emirates (UAE) were not considered
in the ecological analysis because no information
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Figure 2. Prevalence of intestinal metaplasia in Helicobacter
pylori-infected subjects as a function of tobacco availability.
ARG: Argentina; AUS: Australia; CHN: China; COL: Colombia; CZE: Czech Repu-
blic; DEU: Germany; EGY: Egypt; FIN: Finland; GMB: Gambia;  IND: India; IRN: Iran;
IRL: Ireland; ITA: Italy; JPN: Japan; KOR: Republic of Korea;  MEX: Mexico; NGA:
Nigeria; NLD: Netherlands; NZL: New Zealand; PER: Peru; PRT: Portugal; SAU: Saudi
Arabia; SWE: Sweden; THA: Thailand; TUR: Turkey; GBR: United Kingdom; USA:
United States of America; VEN: Venezuela.
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could be obtained for tobacco availability. However, when
a value equal to their nearest neighbour (Saudi Arabia)
was applied as an estimate for the UAE, the correla-
tions between IM prevalence and smoking remained the
same (r = 0.45; p = 0.01).
Our results show an area-level association betwe-
en exposure to tobacco and IM prevalence in H. pylo-
ri-infected subjects, providing ecological support to the
hypothesis that smoking is a risk factor for IM among
the infected population. This is in agreement with the
known increased risk of IM associated with tobacco con-
sumption14-16 and with the results of previous studies that
suggest a synergistic effect between smoking and H.
pylori infection for stomach cancer32,36. The stronger as-
sociation between smoking and IM17,67 compared to the
relatively low increase in the risk of gastric cancer among
smokers10,68 and the low rate of progression from ch-
ronic atrophic gastritis to IM observed in Kenya69 sug-
gest that smoking plays a modulating role in this spe-
cific step of carcinogenesis.
It would have been interesting to have been able to
account for the potential influence of genetic and other
environmental factors on regional variations in the pre-
valence of IM among H. pylori-infected individuals. H.
pylori isolates from high-risk stomach cancer popula-
tions may differ genetically from those from low-risk
areas, but the presence of cagA (the only virulence mar-
ker available for a relatively large number of countries)
may be of limited value in explaining these apparent
«enigmas» as there is also a high prevalence of cagA+
strains in countries with anticipated low frequencies of
intestinal metaplasia33,70-73.
Our study shows that IM is relatively infrequent in H.
pylori-infected subjects from African and Asian countries.
They present a simultaneously high prevalence of in-
fection and low incidence of gastric cancer (Egypt, Gam-
bia, Nigeria, India, Iran, Saudi Arabia and Thailand), which
serves to extend the concept of the African and Asian
«enigmas» to precancerous lesions. Tobacco availabi-
lity was positively associated with the prevalence of IM
among H. pylori-infected subjects at the area-level.
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Comment. Gastric intestinal metaplasia 
and smoking
(Comentario. Metaplasia intestinal gástrica y tabaco)
Carlos A. González
Catalan Institute of Oncology, Barcelona, Spain.
Although the pathogenesis of intestinal metaplasia remains
unknown1, it is well recognized that chronic gastritis and in-
testinal metaplasia are precursor conditions of gastric can-
cer. In intestinal metaplasia, the original gastric mucosa is re-
placed by glandular structures bearing an intestinal phenotype.
Intestinal metaplasia is one of several steps in the prolonged
precancerous process of gastric cancer, mostly of the intes-
tinal histological type. There are 2 other types of intestinal
metaplasia: the complite (tpe I) and the incomplite (tpe III)
type. The incomplite type is more frequently associated with
dysplasia and early carcinoma and is considered a more ad-
vanced stage of the process or of higher malignant poten-
tial2.
On the other hand, there is enough evidence about the
causal relationship between smoking and gastric cancer risk3.
The study by Peleteiro and colleagues deals with a systematic
review of prevalence of intestinal metaplasia among Helico-
bacter pylori infected individuals and the correlation with na-
tional tobacco availability by means of an ecological ana-
lysis4.
Several case-control studies have shown the association
between intestinal metaplasia and smoking. Although an eco-
logical study is not the best appropiate epidemiological design
to support the hypothesis of the role of smoking in the risk of
intestinal metaplasia or in the progression from intestinal me-
taplasia to gastric cancer, there are no reviews published on
the prevalence of intestinal metaplasia. This study provides
a large, detailed, and useful information about the prevalen-
ce of intestinal metaplasia in 29 countries of five continents.
Nevertheless, caution should be taken when the prevalence
of intestinal metaplasia between studies and countries. The
population source (clinical- or population-based), the age and
the sex of participants, as well as the number of biopsies spe-
cimens, and the biopsy site, may influence the prevalence of
intestinal metaplasia and therefore the comparability of results
from different studies.
Information of tobacco availability in each country, expres-
sed as the adult apparent tobacco consumption in cigarettes
per day, were obtained from the Tobacco and Health Report of
the WHO or from the National Tobacco Information Online Sys-
tem database, which provide realiable information at the po-
pulation level. Despite the importance of these results, it is ne-
cessary to stress that causal relationships can be only derived
from individual exposure data from studies to come.
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